Annual Short Term Debt
$7.88 M
+$7.78 M+8132.81%
December 31, 2023
Summary
- As of February 8, 2025, EPRX annual short term debt is $7.88 million, with the most recent change of +$7.78 million (+8132.81%) on December 31, 2023.
- During the last 3 years, EPRX annual short term debt has fallen by -$1.98 million (-20.07%).
- EPRX annual short term debt is now -20.07% below its all-time high of $9.86 million, reached on December 1, 2020.
Performance
EPRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$78.80 K
-$4.55 M-98.30%
September 1, 2024
Summary
- As of February 8, 2025, EPRX quarterly short term debt is $78.80 thousand, with the most recent change of -$4.55 million (-98.30%) on September 1, 2024.
- Over the past year, EPRX quarterly short term debt has dropped by -$4.55 million (-98.30%).
- EPRX quarterly short term debt is now -99.30% below its all-time high of $11.33 million, reached on September 30, 2023.
Performance
EPRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
EPRX Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +8132.8% | -98.3% |
3 y3 years | -20.1% | -35.1% |
5 y5 years | +182.9% | - |
EPRX Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +8132.8% | -99.3% | at low |
5 y | 5-year | -20.1% | +8132.8% | -99.3% | +74.0% |
alltime | all time | -20.1% | >+9999.0% | -99.3% | +74.0% |
Eupraxia Pharmaceuticals Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $78.80 K(-98.3%) |
Jun 2024 | - | $4.63 M(-51.6%) |
Mar 2024 | - | $9.56 M(-8.6%) |
Dec 2023 | $7.88 M(+8132.8%) | $10.45 M(-7.8%) |
Sep 2023 | - | $11.33 M(+35.6%) |
Jun 2023 | - | $8.36 M(+6338.4%) |
Dec 2022 | $95.70 K | - |
Dec 2022 | - | $129.80 K(+2.4%) |
Sep 2022 | - | $126.80 K(0.0%) |
Jun 2022 | - | $126.80 K(+0.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $125.70 K(+3.5%) |
Dec 2021 | $121.40 K(-98.8%) | $121.40 K(+1.8%) |
Sep 2021 | - | $119.20 K(+163.1%) |
Jun 2021 | - | $45.30 K(-99.1%) |
Mar 2021 | - | $4.89 M(-50.4%) |
Dec 2020 | $9.86 M(+10.2%) | $9.86 M(+6.2%) |
Sep 2020 | - | $9.28 M(+3.8%) |
Dec 2019 | $8.95 M(+221.2%) | $8.95 M |
Dec 2018 | $2.78 M(>+9900.0%) | - |
Dec 2017 | $5800.00 | - |
FAQ
- What is Eupraxia Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual short term debt year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly short term debt year-on-year change?
What is Eupraxia Pharmaceuticals annual short term debt?
The current annual short term debt of EPRX is $7.88 M
What is the all time high annual short term debt for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual short term debt is $9.86 M
What is Eupraxia Pharmaceuticals annual short term debt year-on-year change?
Over the past year, EPRX annual short term debt has changed by +$7.78 M (+8132.81%)
What is Eupraxia Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of EPRX is $78.80 K
What is the all time high quarterly short term debt for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly short term debt is $11.33 M
What is Eupraxia Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, EPRX quarterly short term debt has changed by -$4.55 M (-98.30%)